Advisory Committees: US FDA Standardizing Decisions On When To Vet Applications

 
• By Sue Sutter
Palm trees
Office of New Drugs' Peter Stein wants to shake some trees to find clinicians who manage rare disease patients. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers